Jo mama- ITC will not outright deny an Amarin victory...it will be a “slow walk” to inaction. Amarin would then report the violations to FDA, likely not public. After an FDA noncompliance and failure to enforce Amarin will have an actionable argument... The FDA is aware of R-I and the FDA’s abilities to win any argument decreases as we approach the final R-I results. It’s not a matter of if the FDA loses, but how much they lose. I haven’t emailed Woodcock lately, but I certainly plan to in the coming months...if she wants her career to end with R-I that’s fine by me.